Indoco Remedies Limited Stock: price and insider trades · India

Indoco Remedies Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). In the past year (23 October 2025 to 23 October 2026), 14 filings came from 9 insiders.

No insider sold shares on the market over the period. Instead, the filings list 6 purchases totalling €106k, made by 4 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 2 major shareholders and 2 senior executives. The largest single trade was a purchase of €31k by Aruna Suresh Kare, published on 9 September 2026, equal to 0.016% of the market capitalisation.

With 14 filings in twelve months, the company is more active than the median of 4 filings across the 1,892 companies we follow on the same exchange. Since 2023, the database holds 50 purchases and 3 sales by insiders of the company.

Within a 30-day window, 6 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase dates back some time: it was published 45 days ago, on 9 September 2026. The median gap between a trade and its publication by SEBI (PIT + SAST) is 2 days. Until a filing is published, the market cannot know about the trade.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.